OpenFilings

GT Biopharma, Inc.

Form8-K

Report Period2026-09-02

Date Filed2026-09-03

Time Filed11:45:15

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-3.5
EX-3.6
EX-3.7
EX-3.8
EX-3.9
EX-3.10
EX-3.11
EX-3.12
Filing on SEC Edgar